Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics: Elio Plasma Complete

Personal Genome Diagnostics has launched its Elio Plasma Complete assay, a next-generation sequencing (NGS) kit for comprehensive blood-based genomic analysis. The research-use-only kit analyzes circulating cell-free tumor DNA (cfDNA) for genetic alterations in cancer. The firm said the assay evaluates even low-abundance sample DNA and processes samples using a NGS panel of 521 genes. PGDx added that the kit also includes automated bioinformatics that helps identify somatic mutations within cfDNA with high sensitivity and specificity. 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.